Katherine R Tuttle MD

Physician

105 W 8th AveSte 7060Spokane, WA 99204
Phone+1 509-340-0930
Fax+1 509-462-4086

Dr. Tuttle is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tuttle's full profile Already have an account?

Summary

Dr. Katherine Tuttle is a nephrology specialist based in Spokane, WA. She earned her medical degree from Northwestern University The Feinberg School of Medicine in 1982, completed her internship and residency in Internal Medicine at McGaw Medical Center of Northwestern University, and pursued a fellowship in Nephrology at the University of Texas Health Science Center San Antonio. Her recent publications address topics such as metabolic, cardiovascular, and renal benefits of receptor agonists, and have appeared in esteemed journals like Lancet and Nature Reviews Nephrology. She has served as a principal investigator and in other roles for various clinical trials focused on chronic kidney disease and medication interventions. Dr. Tuttle is recognized as a Fellow by the American Society of Nephrology.

Education & Training

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Nephrology, 1986 - 1988
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1983 - 1985
McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 1982 - 1983
Northwestern University The Feinberg School of MedicineClass of 1982

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

ID State Medical License 1991 - 2030
WA State Medical License 1991 - 2028
TX State Medical License 1988 - 1991
IL State Medical License 1984 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

Fellow (ASNF) American Society of Nephrology

Clinical Trials

The Heart Institute of Spokane Diet Study
COMPLETED
PHASE3
Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
COMPLETED
NA
Angiotensin II Antagonism of TGF-Beta 1
COMPLETED
NA

Publications & Presentations

PubMed

Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.
Rodolfo J Galindo, Bobak Moazzami, Amany Gerges, Ina Flores, Giuliana Arevalo
Diabetes Care. 2026-09-01
Comparison of Specific Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes Among Patients With Type 2 Diabetes.
Joshua J Neumiller, Yihong Deng, Kavya Sindhu Swarna, Eric C Polley, Jeph Herrin
American Journal of Kidney Diseases. 2026-09-01
Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis.
Johannes F E Mann, Sunil V Badve, Florian M M Baeres, Nicolas Belmar, Kirstine Brown-Frandsen
The Lancet. Diabetes & Endocrinology. 2026-08-07

Journal Articles

Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease
Katherine Tuttle, MD, American Society of Nephrology

Authored Content

Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney DiseaseFebruary 2020
Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney DiseaseMarch 2018

Press Mentions

Highlights from Kidney Week 2025November 21st, 2025
Top Diabetes Drugs Still Miss Many PatientsJuly 4th, 2025
Novel Diabetes Drugs Promise a New Era in Kidney CareNovember 6th, 2024

Grant Support

Role Of The Kidney In The Hypercalcemia In MalignancyNational Center For Research Resources1990
Pathophysiology Of Glomerular Hyperfilteration In DiabetesNational Center For Research Resources1990